Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Ureteral Neoplasms × tocilizumab × Clear all

Sponsor

Conditions

Arthritis, Rheumatoid 4 Lymphoma, B-Cell 2 Hematologic Neoplasms 2 Breast Neoplasms 2 Stomach Neoplasms 1 Spondylitis, Ankylosing 1 Solid Tumors 1 Sarcoma, Kaposi 1 Respiratory Tract Infections 1 Respiratory Distress Syndrome 1 Pneumonia 1 Pancreatic Neoplasms 1 Pancreatic Adenocarcinoma 1 Nasopharyngeal Neoplasms 1 Multi-centric Castleman's Disease 1 Mesothelioma 1 Melanoma 1 Lymphoma, Non-Hodgkin 1 Liver Neoplasms 1 Kidney Neoplasms 1 Esophageal Neoplasms 1 Castleman Disease 1 Carcinoma, Non-Small-Cell Lung 1 Carcinoma, Hepatocellular 1 COVID-19 1 Biliary Tract Neoplasms 1 Acquired Immunodeficiency Syndrome 1

Interventions

Gemcitabine 5 Cisplatin 4 enfortumab vedotin 2 Ramucirumab 2 Platinum 2 Docetaxel 2 1,2-diaminocyclohexaneplatinum II citrate 2 vinflunine 1 rucaparib 1 pembrolizumab 1 eribulin 1 enzalutamide 1 dehydroftorafur 1 carotuximab 1 avelumab 1 atezolizumab 1 Standard of Care 1 Specimen Handling 1 Radiotherapy 1 Radiation 1 Paclitaxel 1 N-(3-aminopropyl)-N-(1-(5-benzyl-3-methyl-4-oxo-(1,2)thiazolo(5,4-d)pyrimidin-6-yl)-2-methylpropyl)-4-methylbenzamide 1 Mitozytrex 1 Mitomycin 1 Magnetic Resonance Spectroscopy 1 Interleukin-7 1 Immunoglobulin G 1 Icrucumab 1 IMC-18F1 1 Fluorouracil 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡